Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Multi-center, International Prospective Follow up Study
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- Medi-Tate Ltd.
- Target Recruit Count
- 17
- Registration Number
- NCT04579913
- Locations
- 🇺🇸
Clinical Research Center of Florida, Pompano Beach, Florida, United States
🇺🇸Manhattan Medical research, Manhattan, New York, United States
🇺🇸Premier Urology Group, New York, New York, United States
A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI
- Conditions
- BPH
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- Medi-Tate Ltd.
- Target Recruit Count
- 1
- Registration Number
- NCT03994263
- Locations
- 🇩🇪
Kliniken Nordoberpfalz AG Klinik für Urologie, Kinderurologie und interdisziplinäres Prostatakarzinomzentrum, Weiden, Germany
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
- Conditions
- BPH
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Medi-Tate Ltd.
- Target Recruit Count
- 149
- Registration Number
- NCT03395522
- Locations
- 🇦🇺
Sydney Adventist Hospital Clinical School of the University of Sydney, Sydney, Australia
🇫🇷Hospital Center University De Bordeaux, Bordeaux, France
🇫🇷Hôpital Cochin, Paris, France
Study to Assess the Efficacy, Safety and Tolerability of (iTind)
- Conditions
- BPH
- First Posted Date
- 2017-08-04
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Medi-Tate Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT03239951
- Locations
- 🇬🇧
Firmly Park Hospital, Frimley, United Kingdom
🇬🇧King's college, London, United Kingdom
🇬🇧Norwich University Hospital, Norwich, United Kingdom
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
- Conditions
- Benign Prostate Hyperplasia
- First Posted Date
- 2015-07-23
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Medi-Tate Ltd.
- Target Recruit Count
- 185
- Registration Number
- NCT02506465
- Locations
- 🇺🇸
Clinical Research Center of Florida, Pompano Beach, Florida, United States
🇺🇸Chesapeake Urology Research Associates, Baltimore, Maryland, United States
🇺🇸Methodist Hospital, Brooklyn, New York, United States
- Prev
- 1
- 2
- Next